We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+3.36%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$24.6B
AUM Growth
-$4.32B
(-15%)
Cap. Flow
-$4.58B
Cap. Flow
% of AUM
-18.6%
Top 10 Holdings %
Top 10 Hldgs %
35.76%
Holding
1,158
New
25
Increased
204
Reduced
826
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI South Korea ETF
EWY
|
+$417M |
| 2 |
Tesla
TSLA
|
+$152M |
| 3 |
Broadcom
AVGO
|
+$74.2M |
| 4 |
Qualcomm
QCOM
|
+$39.4M |
| 5 |
Marvell Technology
MRVL
|
+$24.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$341M |
| 3 |
Applied Materials
AMAT
|
+$243M |
| 4 |
Lam Research
LRCX
|
+$194M |
| 5 |
NVIDIA
NVDA
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 48.84% |
| 2 | Financials | 8.23% |
| 3 | Consumer Discretionary | 5.72% |
| 4 | Healthcare | 3.78% |
| 5 | Industrials | 3.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Apogee Therapeutics
APGE
$10.2B
| $5.08M | 0.02% |
60,397
+11,778
| +24% | +$855K |
|
352
Digital Realty Trust
DLR
$66.8B
| $5.06M | 0.02% |
28,072
-10,666
| -28% | -$1.82M |
|
353
NetApp
NTAP
$32.6B
| $5.04M | 0.02% |
49,259
-16,478
| -25% | -$1.67M |
|
354
Emerson Electric
EMR
$78.1B
| $5.02M | 0.02% |
38,320
-14,403
| -27% | -$2.07M |
|
355
BWX Technologies
BWXT
$16B
| $5.02M | 0.02% |
24,550
+1,996
| +9% | +$405K |
|
356
Elevance Health
ELV
$85.5B
| $4.99M | 0.02% |
17,055
-6,872
| -29% | -$2.26M |
|
357
First Solar
FSLR
$22.4B
| $4.99M | 0.02% |
25,303
-8,342
| -25% | -$1.85M |
|
358
Arrowhead Research
ARWR
$12.6B
| $4.99M | 0.02% |
79,605
-4,864
| -6% | -$308K |
|
359
3M
MMM
$90.6B
| $4.98M | 0.02% |
34,296
-13,028
| -28% | -$2.07M |
|
360
Protagonist Therapeutics
PTGX
$8.76B
| $4.93M | 0.02% |
46,752
-16,909
| -27% | -$1.5M |
|
361
Zions Bancorporation
ZION
$10.2B
| $4.92M | 0.02% |
85,433
-57,822
| -40% | -$3.41M |
|
|
FLG
362
Flagstar Bank National Association
FLG
$6.14B
| $4.92M | 0.02% |
373,516
-267,210
| -42% | -$3.5M |
|
363
Summit Therapeutics
SMMT
$11.7B
| $4.91M | 0.02% |
259,074
-28,736
| -10% | -$465K |
|
364
Praxis Precision Medicines
PRAX
$8.64B
| $4.89M | 0.02% |
15,188
-7,052
| -32% | -$2.18M |
|
365
Textron
TXT
$15.9B
| $4.87M | 0.02% |
55,657
-553
| -1% | -$51.6K |
|
366
Realty Income
O
$60.8B
| $4.86M | 0.02% |
79,457
-30,508
| -28% | -$1.91M |
|
367
Wintrust Financial
WTFC
$10.7B
| $4.85M | 0.02% |
34,892
-24,966
| -42% | -$3.62M |
|
368
Bank OZK
OZK
$5.62B
| $4.84M | 0.02% |
105,511
-67,124
| -39% | -$3.16M |
|
369
Cummins
CMI
$91.3B
| $4.84M | 0.02% |
8,999
-3,297
| -27% | -$1.87M |
|
370
Texas Capital Bancshares
TCBI
$4.46B
| $4.83M | 0.02% |
50,907
-10,134
| -17% | -$988K |
|
371
Associated Banc-Corp
ASB
$5.79B
| $4.83M | 0.02% |
186,730
-51,905
| -22% | -$1.38M |
|
372
East-West Bancorp
EWBC
$17.9B
| $4.83M | 0.02% |
45,195
-29,263
| -39% | -$3.3M |
|
373
Cullen/Frost Bankers
CFR
$10.1B
| $4.82M | 0.02% |
35,162
-29,653
| -46% | -$4.09M |
|
374
Cogent Biosciences
COGT
$6.63B
| $4.81M | 0.02% |
125,013
+13,919
| +13% | +$514K |
|
375
Pinnacle Financial Partners Inc
PNFP
$14.6B
| $4.81M | 0.02% |
55,825
-28,349
| -34% | -$2.64M |
|
Similar funds
CS
AF
SC
RG
JG
Rafferty Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, Rafferty Asset Management held 1,158 positions worth $24.6B, down 15% from $28.9B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Rafferty Asset Management withdrew a net $4.58B in Q1 2026, closing 101 positions and reducing 826 holdings. Its most notable exit was AstraZeneca, an estimated $12.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 49% of assets, up from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Rafferty Asset Management opened a new position in FTAI Aviation worth $6.39M.
- Rafferty Asset Management's largest Q1 2026 buy was FTAI Aviation: 26,098 shares worth $6.39M.
- Rafferty Asset Management added most to iShares MSCI South Korea ETF in Q1 2026, an estimated $417M increase.
- Rafferty Asset Management's biggest Q1 2026 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $647M.
- Rafferty Asset Management fully exited AstraZeneca in Q1 2026, selling an estimated $12.3M.
- Rafferty Asset Management's ten largest holdings make up 36% of its $24.6B portfolio in Q1 2026.
- Rafferty Asset Management opened 25 new positions and closed 101 in Q1 2026.
- Rafferty Asset Management's portfolio value fell 15% quarter-over-quarter to $24.6B.
Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.